Decreased mutagen susceptibility of WNV replication complex mutants. by Greta A. Van Slyke (761322)

Nanoparticle formulation decreases curcumin cytotoxicity. by Upendhar Gandapu (208623)

ApoER2 expression increases Aβ production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulat... by Rodrigo A Fuentealba (77901)

“…Data represent mean ± S.E.M of three experiments in duplicated, presented as fold values of the basal activity. * P < 0.05, ** P < 0.01. (), 50 μg of protein/lane were subjected to 12% SDS-PAGE and endogenous PS1 levels were determined by Western blot. …”

Resveratrol decreases PKM2 expression. by Mohd Askandar Iqbal (324124)

“…<p>Resveratrol treatment decreases PKM2 mRNA in (A), HeLa; (B), HepG2 and (C), MCF-7; by approximately two-folds. β-actin was taken as endogenous control and normalized to PKM2 mRNA. …”

Stability scores with refinement and no USM decreases. by Jedediah M. Singer (10331212)

“…<p>Effects of guided and random substitutions within GM designs with a maximum sequence identity to any expert-designed protein of less than 50%, when guided substitutions are not permitted to decrease USM EC₅₀ predictions.…”

Quercetin decreased mitochondrial- and intercellular ROS. by Takaya Sugawara (9338487)

Bioluminescence decreases with aging in transgenic mice. by Sarah E. Mailhiot (766685)

Decreased pathology of VLP-treated mice. by Steven B. Bradfute (262649)

Dex decreases dispersal of GBM cells. by Stephen Shannon (784424)

“…<p>(<b>A</b>) Aggregates, ranging in size from 50–70 μm in diameter were plated onto tissue culture plastic in complete medium. …”

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…(C) COA6 cells were treated with GSK343 (0, 5 μM) for 72 hours. qPCR demonstrated a significant decrease in mRNA abundance of known stemness markers Oct4, Nanog, and Sox2 following GSK343 treatment compared to untreated cells. …”

Treatment with mitochondrial shuttle inhibitors, GKA50, Ranolazine and glucose results in significant decreases in superoxide concentration as detected by coelenterazine chemilumin... by Laura L. Bronsart (844933)

A functional PSA mimetic peptide (fPSA) prevents glutamate-induced MAP-2 decrease and concomitant changes in SYN and NCAM synaptic patterns and levels. by María Fernanda Podestá (639243)

“…(B) Quantification of MAP-2 immunoreactive area showed decreased levels 6 h after glutamate exposure; this decrease was prevented by fPSA. …”

siRNA Knockdown of PKCδ decreases phosphorylation of VEEV capsid. by Brian D. Carey (6092747)

Longer polyQ sequences decrease the nuclear localization of AR in the absence of hormone. by Carlos M. Roggero (11909585)

The <i>P[syt^P-L]</i> mutation decreases the Ca²⁺ affinity of release and vesicular release probability, but the readily releasable pool is unchanged. by Mallory C. Shields (4474210)

“…<p>(A) Mean EJP amplitudes from <i>+/-;P[syt^WT]/+</i> (filled black circles) and <i>+/-;P[syt^P-L]/+</i> (filled red circles) larvae at Ca²⁺ levels ranging from 0.05 mM—5.0 mM. …”

Activation of NMDA receptors with D-serine obviously limited the decrease of p-CREB in the hippocampus of the surviving LPS-treated mice. by Shuibing Zhang (4336402)

Velocity distribution at different openings (a) 25%; (b) 50%; (c) 75%; (d) 100%. by Weiqing Xu (1279959)

SMC-specific knockout of Klf5 (smcKlf5^−/−) exacerbates the progression of Ang II–induced AAA by facilitating ROS formation. by Dong Ma (584680)

Klf5 down-regulation leads to human VSMC senescence. by Dong Ma (584680)

Klf5 expression is down-regulated in the ruptured human and experimental AAA. by Dong Ma (584680)